PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 87 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $95,824,065 | -8.1% | 5,744,848 | +52.1% | 2.58% | -11.1% |
| Q2 2023 | $104,290,358 | +20.1% | 3,775,900 | 0.0% | 2.91% | -8.4% |
| Q1 2023 | $86,845,700 | +892.0% | 3,775,900 | +241.1% | 3.18% | +650.6% |
| Q2 2022 | $8,755,000 | -91.2% | 1,106,838 | -73.5% | 0.42% | -89.3% |
| Q1 2022 | $99,059,000 | -20.7% | 4,183,219 | +14.6% | 3.96% | -12.6% |
| Q4 2021 | $124,890,000 | +80.6% | 3,651,759 | -6.4% | 4.53% | +68.1% |
| Q3 2021 | $69,139,000 | -59.0% | 3,901,759 | +3.9% | 2.70% | -57.3% |
| Q2 2021 | $168,484,000 | +64.3% | 3,754,095 | -5.2% | 6.32% | +64.2% |
| Q1 2021 | $102,550,000 | +19.0% | 3,959,451 | -7.4% | 3.84% | +13.5% |
| Q4 2020 | $86,156,000 | +85.8% | 4,273,588 | +80.1% | 3.39% | +34.2% |
| Q3 2020 | $46,378,000 | +10.9% | 2,372,288 | +0.2% | 2.53% | -2.0% |
| Q2 2020 | $41,806,000 | +755.1% | 2,367,288 | +241.9% | 2.58% | +465.4% |
| Q1 2020 | $4,889,000 | +1.6% | 692,430 | +1.4% | 0.46% | +24.9% |
| Q4 2019 | $4,813,000 | -41.3% | 682,630 | 0.0% | 0.36% | -57.6% |
| Q3 2019 | $8,198,000 | -36.4% | 682,630 | -35.8% | 0.86% | -38.8% |
| Q2 2019 | $12,883,000 | -8.8% | 1,063,802 | -5.3% | 1.41% | -11.0% |
| Q1 2019 | $14,119,000 | +28.0% | 1,123,255 | -31.5% | 1.58% | +9.6% |
| Q4 2018 | $11,034,000 | -59.0% | 1,639,458 | -37.4% | 1.44% | -39.1% |
| Q3 2018 | $26,939,000 | +182.7% | 2,617,967 | +84.6% | 2.37% | +154.5% |
| Q2 2018 | $9,529,000 | +173.5% | 1,417,967 | +249.6% | 0.93% | +163.5% |
| Q1 2018 | $3,484,000 | -43.1% | 405,600 | +37.9% | 0.35% | -52.2% |
| Q4 2017 | $6,118,000 | -22.8% | 294,117 | -21.6% | 0.74% | -50.6% |
| Q3 2016 | $7,924,000 | – | 375,000 | – | 1.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |